Invention Grant
- Patent Title: Bicyclic heterocycles as FGFR inhibitors
-
Application No.: US17160628Application Date: 2021-01-28
-
Publication No.: US11530214B2Publication Date: 2022-12-20
- Inventor: Liang Lu , Wenqing Yao , Chunhong He , Fenglei Zhang
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington; US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington; US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K31/4375 ; C07D471/04
Abstract:
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Public/Granted literature
- US20210395246A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Public/Granted day:2021-12-23
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
